Skip to content
DefDex

Federal award

KBR WYLE SERVICES, LLC

0119

Contract

Obligated and Ceiling

Obligated (net)
$23,689,379.05
Ceiling (potential value, not spending)
$24,154,583.00
Current value
$24,154,583.00
Gross positive obligations
$24,121,711.00

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
KBR WYLE SERVICES, LLC · KNV8E5VRLHT9
Owner company
KBRBasis reviewed link: a dated, evidenced ownership link.
Reported parent
KBR, INC. · VJ3XVZC76HT9
Awarding agency
Department of Defense · sub-agency 9763 · office S0107A
Funding agency
Department of Defense · sub-agency 5700
Product or service (PSC)
AZ12 · R&D- OTHER RESEARCH AND DEVELOPMENT (APPLIED RESEARCH/EXPLORATORY DEVELOPMENT)
Industry (NAICS)
541710 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES
PIID
0119
Parent vehicle (IDV PIID)
HC104705D4005
Award type code
C
Actions
25 · Sep 14, 2009 to Mar 15, 2018
Why it is listed
gross positive obligations of $100k or more (contracts); reviewed company, $10k or more

Open this award on USAspending →

Action History25

Award actions
DateFYModAction typeObligationCompany in company totals
Mar 15, 2018FY20181DC−$7,137.10
Aug 4, 2017FY20171CC−$32,861.59
Apr 1, 2016FY20161BC−$183,766.25
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Mar 27, 2015FY20151AC−$208,567.01
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Jun 14, 2012FY201220C$198,610.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Dec 7, 2011FY201219C$126,629.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Aug 18, 2011FY201118C$50,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Jul 21, 2011FY201117C$277,037.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Jul 19, 2011FY201116C$132,367.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Feb 23, 2011FY201115C$148,736.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Jan 31, 2011FY201114C$120,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Dec 2, 2010FY201113M$0.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Nov 9, 2010FY201112C$49,603.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 15, 2010FY201011C$6,300,915.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 4, 2010FY201010C$175,389.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Aug 30, 2010FY20109C$2,531,312.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
May 6, 2010FY20108C$8,084,730.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
May 3, 2010FY20107C$1,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
May 3, 2010FY20106C$116,785.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Apr 26, 2010FY20105C$409,935.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Jan 25, 2010FY20104A$2,505,314.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Oct 29, 2009FY20103B$0.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 29, 2009FY20092C$100,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 24, 2009FY20091C$2,630,000.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)
Sep 14, 2009FY20090—$163,349.00
Wyle Laboratories
Counted for Wyle Laboratories in company totals (direct)

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.